TODENTJ-25-03-2019_TODENTJ-4-172 1553505192 Bentham Open doi@benthamopen.net Bentham Open The Open Dentistry Journal TODENTJ 1874-2106 8 27 2010 4 1 Anastasios K. Markopoulos Evangelia Z. Michailidou Georgios Tzimagiorgis Oral cancer refers to all malignancies that arise in the oral cavity, lips and pharynx, with 90% of all oral cancers being oral squamous cell carcinoma. Despite the recent treatment advances, oral cancer is reported as having one of the highest mortality ratios amongst other malignancies and this can much be attributed to the late diagnosis of the disease. Saliva has long been tested as a valuable tool for drug monitoring and the diagnosis systemic diseases among which oral cancer. The new emerging technologies in molecular biology have enabled the discovery of new molecular markers (DNA, RNA and protein markers) for oral cancer diagnosis and surveillance which are discussed in the current review. 8 27 2010 172 178 TODENTJ-4-172 1 10.2174/crossmark_policy opendentistryjournal.com benthamopen.com true Peer Reviewed Single blind Checked with iThenticate 2010-3-28 2010-6-9 2010-7-20 2010-8-27 http://creativecommons.org/licenses/by-nc/3.0/ 10.2174/1874210601004010172 1553505192 https://opendentistryjournal.com/VOLUME/4/PAGE/172/ https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.pdf https://opendentistryjournal.com/contents/volumes/V4/TODENTJ-4-172/TODENTJ-4-172.xml The international statistical classification of diseases and related health problems 1 In: World Health Organization; Geneva. 1992. (10 ) American Cancer Society. Cancer Facts and Figures 2007. Atlanta: American Cancer Society 2007. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000, cancer incidence, mortality and prevalence worldwide, Version 10. Lyon: IARC Press 2001. Peacock S, Pogrel A, Schmidt BL. Exploring the reasons for delay in treatment of oral cancer Am Dent Assoc 2008; 139 : 1346-52. Eur Arch Otorhinolaryngol Schantz SP 250 424 1993 Schantz SP. Biologic markers, cellular differentiation, and metastatic head and neck cancer Eur Arch Otorhinolaryngol 1993; 250 : 424-8. Curr Opin Oncol Schantz SP 5 483 1993 Schantz SP. Carcinogenesis, markers, staging, and prognosis of head and neck cancer Curr Opin Oncol 1993; 5 : 483-90. Nat Rev Cancer Sidransky D 3 210 2002 Sidransky D. Emerging molecular markers of cancer Nat Rev Cancer 2002; 3 : 210-9. Surg Oncol Clin N Am Ellison MD 8 725 1999 Ellison MD, Campbell BH. Screening for cancer of the head and neck: addressing the problem Surg Oncol Clin N Am 1999; 8 : 725-34. Head Neck Oncol Fedele S 30 1 2009 Fedele S. Diagnostic aids in the screening of oral cancer Head Neck Oncol 2009; 30 : 1-5. Med Oral Patol Oral Cir Buccal Trullenque-Eriksson A 14 E210 2009 Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa Med Oral Patol Oral Cir Buccal 2009; 14 : E210. Otolaryngol Head Neck Surg Dolan RW 118 463 1998 Dolan RW, Vaughan CW, Fuleihan N. Symptoms in early head and neck cancer: an inadequate indicator Otolaryngol Head Neck Surg 1998; 118 : 463-7. Sankila R, Coll EC. Evaluation and monitoring of screening program. Luxembourg: Office for the Official Publication of the European Communities 2001; pp. 243-54. Cancer Detect Prev http://www.jdentaled.org/cgi/external_ref?access_num=1751941&l ink_type=MED Warnakulasuriya S 15 331 1991 Warnakulasuriya S, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka Cancer Detect Prev http://www.jdentaled.org/cgi/external_ref?access_num=1751941&l ink_type=MED 1991; 15 : 331-4. Commun Dent Health Zakzerwska JM 10 79 1993 Zakzerwska JM, Hindle I, Speight PM. Practical considerations for the establishment of an oral cancer screening programme Commun Dent Health 1993; 10 (Suppl 1 ) : 79-85. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Onofre MA 91 535 2001 Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91 : 535-40. Cancer Res Zhang L 65 8017 2005 Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome Cancer Res 2005; 65 : 8017-21. J Am Dent Assoc Christian DC 133 357 2002 Christian DC. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program J Am Dent Assoc 2002; 133 : 357-62. J Oral Pathol Med Mehrotra R 38 161 2009 Mehrotra R, Hullmann M, Smeets R, Reichert TE, Driemel O. Oral cytology revisited J Oral Pathol Med 2009; 38 : 161-6. J Clin Dent Kerr AR 17 59 2006 Kerr AR, Sirois DA, Epstein JB. Clinical evaluation of chemiluminescent lighting:an adjunct for oral mucosal examinations J Clin Dent 2006; 17 : 59-63. Oral Oncol Epstein JB 44 538 2008 Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and tolouidine blue Oral Oncol 2008; 44 : 538-44. Cancer Lett Onizawa K 108 61 1996 Onizawa K, Saginoya H, Furuya Y, Yoshida H. Fluorescence photography as a diagnostic method for oral cancer Cancer Lett 1996; 108 : 61-. Aust Dent J Kujan O 54 170 2009 Kujan O, Glenny AM, Oliver R, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer Aust Dent J 2009; 54 : 170-2. J Dent Educ Omar K 69 255 2005 Omar K, Glenny A, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a cohrane systematic review J Dent Educ 2005; 69 : 255-65. Cancer Res Farber E 44 4217 1984 Farber E. The multistep nature of cancer development Cancer Res 1984; 44 : 4217-23. Clin Lab Med Bigler LR 29 71 2009 Bigler LR, Streckfus CF, Dubinsky WP. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity Clin Lab Med 2009; 29 : 71-85. Clin Cancer Res Streckfus C 6 2363 2000 Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study Clin Cancer Res 2000; 6 : 2363-70. Lung Cancer Schmidt B 48 145 2005 Schmidt B, Engel E, Carstensen T, et al. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer 2005; 48 : 145-7. Ann NY Acad Sci Kopreski MS 945 172 2001 Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum Ann NY Acad Sci 2001; 945 : 172-8. Oncol Rep Hasselmann DO 8 115 2001 Hasselmann DO, Rappl G, Rössler M, Ugurel S, Tilgen W, Reinhold U. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma Oncol Rep 2001; 8 : 115-8. Ann NY Acad Sci Bryzgunova OE 1075 334 2006 Bryzgunova OE, Skvortsova TE, Kolesnikova EV, et al. Isolation and comparative study of cell-free nucleic acids from human urine Ann NY Acad Sci 2006; 1075 : 334-4. Int J Oncol Yoneda K 35 33 2009 Yoneda K, Iida H, Endo H, et al. Identification of cystatin SN as a novel tumor marker for colorectal cancer Int J Oncol 2009; 35 : 33-40. Arch Otolaryngol Head Neck Surg St John M 130 929 2004 St John M, Li Y, Zhou X, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma Arch Otolaryngol Head Neck Surg 2004; 130 : 929-35. Clin Cancer Res Li Y 10 8442 2004 Li Y, St John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection Clin Cancer Res 2004; 10 : 8442-50. Int J Cancer de Bont JM 123 594 2008 de Bont JM, van Doorn J, Reddingius RE, et al. Various components of the insulin-like growth factor system in tumour tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients Int J Cancer 2008; 123 : 594-600. Clin Chem Johnson PJ 48 1186 2002 Johnson PJ, Lo YM. Plasma nucleic acids in the diagnosis and management of malignant disease Clin Chem 2002; 48 : 1186-93. Clin Biochem Neves AF 41 1191 2008 Neves AF, Araújo TG, Biase WK, et al. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer di-agnosis Clin Biochem 2008; 41 : 1191-8. Surgery Honma H 139 678 2006 Honma H, Kanda T, Ito H, et al. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma Surgery 2006; 139 : 678-85. Br J Biomed Sci El-Abd E 65 90 2008 El-Abd E, El-Tahan R, Fahmy L, et al. Serum metastasin mRNA is an important survival predictor in breast cancer Br J Biomed Sci 2008; 65 : 90-4. Br J Cancer Voorzanger-Rousselot N 97 964 2007 Voorzanger-Rousselot N, Goehrig D, Journe F, et al. Increased Dickkopf-1 expression in breast cancer bone metastases Br J Cancer 2007; 97 : 964-70. Urology Siddiqua A 60 270 2002 Siddiqua A, Chendil D, Rowland R, et al. Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer Urology 2002; 60 : 270-5. Urol Res Ogawa O 27 291 1999 Ogawa O, Iinuma M, Sato K, et al. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy Urol Res 1999; 27 : 291-6. J Dent Res Mandel ID 66 623 1987 Mandel ID. The functions of saliva J Dent Res 1987; 66 : 623-7. Compend Suppl Sreebny LM 13 S461 1989 Sreebny LM. Salivary flow in health and disease Compend Suppl 1989; 13 : S461-9. Crit Rev Oral Biol Med Kaufman E 13 197 2002 Kaufman E, Lamster I. The diagnostic applications of saliva: a review Crit Rev Oral Biol Med 2002; 13 : 197-212. Oral Dis Streckfus CF 8 69 2002 Streckfus CF, Bigler L. Saliva as a diagnostic fluid Oral Dis 2002; 8 : 69-76. Br Med J Malamud D 8 207 1992 Malamud D. Saliva as a diagnostic fluid Br Med J 1992; 8 : 207-8. Int Dent J Samaranayake L 57 295 2007 Samaranayake L. Saliva as a diagnostic fluid Int Dent J 2007; 57 : 295-9. Caries Res Fox PC 38 241 2004 Fox PC. Salivary enhancement therapies Caries Res 2004; 38 : 241-6. Oral Dis da Mata AD 15 220 2009 da Mata AD, da Silva Marques DN, Silveira JM, et al. Effects of gustatory stimulants of salivary secretion on salivary pH and flow: a randomized controlled trial Oral Dis 2009; 15 : 220-8. Ann NY Acad Sci Navazesh M 8 72 1993 Navazesh M. Methods for collecting saliva Ann NY Acad Sci 1993; 8 : 72-. Clin Chem Bosker WM 55 1910 2009 Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse Clin Chem 2009; 55 : 1910-31. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Pink R 153 103 2009 Pink R, Simek J, Vondrakova J, et al. Saliva as a diagnostic medium Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009; 153 : 103-. AIDS Patient Care STDS Roberts KJ 21 621 2007 Roberts KJ, Grusky O, Swanson AN. Outcomes of blood and oral fluid rapid HIV testing: a literature review, 2000-2006 AIDS Patient Care STDS 2007; 21 : 621-37. Expert Rev Proteomics Giusti L 4 757 2007 Giusti L, Baldini C, Bazzichi L, Bombardieri S, Lucacchini A. Proteomic diagnosis of Sjögren's syndrome Expert Rev Proteomics 2007; 4 : 757-67. Adv Dent Res Sreebny LM 10 17 1996 Sreebny LM, Zhu WX. The use of whole saliva in the differential diagnosis of Sjögren's syndrome Adv Dent Res 1996; 10 : 17-24. Oral Oncol Zimmermann BG 44 425 2008 Zimmermann BG, Wong DT. Salivary mRNA targets for cancer diagnostics Oral Oncol 2008; 44 : 425-9. Obstet Gynecol Di-Xia C 8 701 1990 Di-Xia C, Schwartz P, Fan-Qin L. Salivary and serum CA 125 assays for detecting malignant ovarian tumors Obstet Gynecol 1990; 8 : 701-4. Crit Rev Oral Biol Med Kaufman E 13 197 2002 Kaufman E, Lamster IB. The diagnostic applications of saliva: a review Crit Rev Oral Biol Med 2002; 13 : 197-212. Ann NY Acad Sci Baum BJ 694 17 1993 Baum BJ. Principles of saliva secretion Ann NY Acad Sci 1993; 694 : 17-23. Eur J Clin Chem Clin Biochem Haeckel R 34 171 1996 Haeckel R, Hanecke P. Application of saliva for drug monitoring: an In vivo model for transmembrane transport Eur J Clin Chem Clin Biochem 1996; 34 : 171-91. Forensic Sci Int Aps JK 150 119 2005 Aps JK, Martens LC. Review: the physiology of saliva and transfer of drugs into saliva Forensic Sci Int 2005; 150 : 119-31. Exp Cell Res Halicka HD 260 248 2000 Halicka HD, Bedner E, Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis Exp Cell Res 2000; 260 : 248-56. Clin Chem Hasselmann D 47 1488 2001 Hasselmann D, Rappl G, Tilgen W, Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degra-dation in human serum Clin Chem 2001; 47 : 1488-9. Leukemia Ratajczak J 20 1487 2006 Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication Leukemia 2006; 20 : 1487-95. Expert Rev Proteomics Simpson RJ 6 267 2009 Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential Expert Rev Proteomics 2009; 6 : 267-83. RNA García JM 14 1424 2008 García JM, García V, Peña C, et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched RNA 2008; 14 : 1424-32. PLoS One Yuan A 4 e4722 2009 Yuan A, Farber E, Rapoport A, et al. Transfer of microRNAs by embryonic stem cell microvesicles PLoS One 2009; 4 : e4722. Nat Cell Biol Skog J 10 1470 2008 Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and pro-vide diagnostic biomarkers Nat Cell Biol 2008; 10 : 1470-6. Proteomics Simpson RJ 8 4083 2008 Simpson RJ, Jensen SS, Lim JW, et al. Proteomic profiling of exosomes: current perspectives Proteomics 2008; 8 : 4083-99. Cell Cycle Al-Nedawi K 8 2014 2009 Al-Nedawi K, Meehan B, Rak J. Microvesicles: messengers and mediators of tumor progression Cell Cycle 2009; 8 : 2014-8. Best Pract Res Clin Haematol Aharon A 22 61 2009 Aharon A, Brenner B. Microparticles, thrombosis and cancer Best Pract Res Clin Haematol 2009; 22 : 61-9. Cancer Res Nawroz H 54 1152 1994 Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma Cancer Res 1994; 54 : 1152-5. Science Fliss MS 287 2017 2000 Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids Science 2000; 287 : 2017-9. Oral Oncol Liao PH 36 272 2000 Liao PH, Chang YC, Huang MF, Tai KW, Chou MY. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas Oral Oncol 2000; 36 : 272-6. Cancer Res Boyle JO 53 4477 1993 Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res 1993; 53 : 4477-80. Cancer Res Rosas SL 61 939 2001 Rosas SL, Koch W, Carvalho MGC, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients Cancer Res 2001; 61 : 939-42. Laryngoscope Vielba R 113 167 2003 Vielba R, Bilbao J, Ispizua A, et al. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx Laryngoscope 2003; 113 : 167-72. Br J Cancer Shpitzer T 101 1194 2009 Shpitzer T, Hamzany Y, Bahar G, et al. Salivary analysis of oral cancer biomarkers Br J Cancer 2009; 101 : 1194-8. Nat Med Chen XQ 2 1033 1996 Chen XQ, Stroun M, Magnenat JL, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients Nat Med 1996; 2 : 1033-5. Cancer Paz IB 79 595 1997 Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring Cancer 1997; 79 : 595-604. Hum Pathol Shimakage M 33 608 2002 Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T, Sasagawa T. Association of Epstein-Barr virus with oral cancers Hum Pathol 2002; 33 : 608-14. Arch Biochem Biophys Eichel HJ 107 197 1964 Eichel HJ, Conger N, Chernick WS. Acid and alkaline ribonucleases of human parotid, submaxillary, and whole saliva Arch Biochem Biophys 1964; 107 : 197-208. Clin Cancer Res Kumar SV 12 5033 2006 Kumar SV, Hurteau GJ, Spivack SD. Validity of messenger RNA expression analyses of human saliva Clin Cancer Res 2006; 12 : 5033-9. Clin Chem Hu Z 54 824 2008 Hu Z, Zimmermann BG, Zhou H, et al. Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids Clin Chem 2008; 54 : 824-32. Clin Cancer Res Park NJ 15 5473 2009 Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection Clin Cancer Res 2009; 15 : 5473-7. Oral Dis Michael A 16 34 2010 Michael A, Bajracharya SD, Yuen PS, et al. Exosomes from human saliva as a source of microRNA biomarkers Oral Dis 2010; 16 : 34-8. Anal Biochem Hanson EK 387 303 2009 Hanson EK, Lubenow H, Ballantyne J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs Anal Biochem 2009; 387 : 303-14. Forensic Sci Int Juusola J 152 1 2005 Juusola J, Ballantyne J. Multiplex mRNA profiling for the identification of body fluids Forensic Sci Int 2005; 152 : 1-12. Forensic Sci Int Juusola J 135 85 2003 Juusola J, Ballantyne J. Messenger RNA profiling: a prototype method to supplant conventional methods for body fluid identifica-tion Forensic Sci Int 2003; 135 : 85-96. Arthritis Rheum Hu S 56 3588 2007 Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome Arthritis Rheum 2007; 56 : 3588-600. Proc Natl Acad Sci USA Seugnet L 103 19913 2006 Seugnet L, Boero J, Gottschalk L, Duntley S, Shaw P. Identification of a biomarker for sleep drive in flies and humans Proc Natl Acad Sci USA 2006; 103 : 19913-8. Blood Lichtenstein A 68 1407 1986 Lichtenstein A, Ganz T, Selsted ME, Lehrer RI. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes Blood 1986; 68 : 1407-0. Cell Lehrer RI 64 229 1991 Lehrer RI, Ganz T, Selsted ME. Defensins: endogenous antibiotic peptides of animal cells Cell 1991; 64 : 229-30. Anticancer Res Mizukawa N 18 4645 1998 Mizukawa N, Sugiyama K, Fukunaga J, et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients Anticancer Res 1998; 18 : 4645-9. Cancer Epidemiol Biomarkers Prev Franzmann EJ 16 1348 2007 Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer Cancer Epidemiol Biomarkers Prev 2007; 16 : 1348-55. Clin Cancer Re Hu S 14 6246 2008 Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery Clin Cancer Re 2008; 14 : 6246-52. Biosens Bioelectron Tan W 24 266 2008 Tan W, Sabet L, Li Y, et al. Optical protein sensor for detecting cancer markers in saliva Biosens Bioelectron 2008; 24 : 266-71. Drug Discov Today Hu S 12 911 2007 Hu S, Yen Y, Ann D, Wong DT. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery Drug Discov Today 2007; 12 : 911-6. Lab Chip Yang CY 5 1017 2005 Yang CY, Brooks E, Li Y, et al. Detection of picomolar levels of interleukin-8 in human saliva by SPR Lab Chip 2005; 5 : 1017-23. Oral Dis Arellano-Garcia ME 14 705 2008 Arellano-Garcia ME, Hu S, Wang J, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva Oral Dis 2008; 14 : 705-12. Int J Oral Maxillofac Surg Kurokawa H 22 35 1993 Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity Int J Oral Maxillofac Surg 1993; 22 : 35-8. J Oral Maxillofac Surg Hoffmann J 56 1390 1998 Hoffmann J, Munz A, Krimmel M, Alfter G. Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma J Oral Maxillofac Surg 1998; 56 : 1390-3. J Craniomaxillofac Surg Krimmel M 26 243 1998 Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SCC-Ag, CEA, CA 19 and CA 125 for diagnosis and follow-up in oral cancer J Craniomaxillofac Surg 1998; 26 : 243-8. Plast Reconstr Surg Nagler RM 100 1697 1997 Nagler RM, Braun J, Daitzman M, Laufer D. Spiral CT angiography - analternative vascular evaluation technique for head and neck microvascular reconstruction: a preliminary experience Plast Reconstr Surg 1997; 100 : 1697-703. J Oral Maxillofac Surg Kurokawa H 55 964 1997 Kurokawa H, Yamashita Y, Tokudome S, Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma J Oral Maxillofac Surg 1997; 55 : 964-6. Cancer Nagler RM 35 1018 1999 Nagler RM, Barak M, Ben-Aryeh H, Peled M, Filatov M, Laufer D. Early diagnostic and treatment monitoring role of Cyfra 21-1 and TPS in oral squamous cell carcinoma Cancer 1999; 35 : 1018-25. Clin Otolaryngol Yen TC 23 82 1998 Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen Clin Otolaryngol 1998; 23 : 82-6. Clin Cancer Res Nagler R 12 3979 2006 Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers: a new diagnostic tool for oral cancer Clin Cancer Res 2006; 12 : 3979-84. Cancer Bahar G 109 54 2007 Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients DNA and protein oxidation, reactive nitrogen species and antioxidant profile Cancer 2007; 109 : 54-9. Cancer Res Clin Oncol Shpitzer T 133 613 2007 Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis Cancer Res Clin Oncol 2007; 133 : 613-7. Ann N Y Acad Sci Pesce MA 1098 192 2007 Pesce MA, Spitalnik SL. Saliva and the clinical pathology laboratory Ann N Y Acad Sci 2007; 1098 : 192-9. Eur J Dent Educ Segal A 12 22 2008 Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and making medicine better Eur J Dent Educ 2008; 12 : 22-9. Expert Rev Mol Diagn Wong DT 6 267 2006 Wong DT. Towards a simple, saliva-based test for the detection of oral cancer. ‘Oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance’ Expert Rev Mol Diagn 2006; 6 : 267-72.